Order Article Reprints

Schirizzi A, Arshadi A, Tolomeo D, Schirosi L, Valentini AM, De Leonardis G, Refolo MG, Donghia R, Storlazzi CT, Zito A, et al. VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines. 2023; 11(10):2721. https://doi.org/10.3390/biomedicines11102721

Schirizzi, Annalisa, Aram Arshadi, Doron Tolomeo, Laura Schirosi, Anna Maria Valentini, Giampiero De Leonardis, Maria Grazia Refolo, Rossella Donghia, Clelia Tiziana Storlazzi, Alfredo Zito, and et al. 2023. "VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment" Biomedicines 11, no. 10: 2721. https://doi.org/10.3390/biomedicines11102721

Schirizzi, A., Arshadi, A., Tolomeo, D., Schirosi, L., Valentini, A. M., De Leonardis, G., Refolo, M. G., Donghia, R., Storlazzi, C. T., Zito, A., Ricci, A. D., Vallarelli, S., Ostuni, C., Bencivenga, M., De Manzoni, G., Messa, C., Armentano, R., Giannelli, G., Lotesoriere, C., & D’Alessandro, R. (2023). VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines, 11(10), 2721. https://doi.org/10.3390/biomedicines11102721